featured
Feasibility and Efficacy of CD19-Targeted CAR T Cells With Concurrent Ibrutinib for CLL After Ibrutinib Failure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Feasibility and Efficacy of CD19-Targeted CAR-T Cells With Concurrent Ibrutinib for CLL After Ibrutinib Failure
Blood 2020 Feb 19;[EPub Ahead of Print], J Gauthier, AV Hirayama, J Purushe, KA Hay, J Lymp, DH Li, CC Yeung, A Sheih, BS Pender, RM Hawkins, A Vakil, TD Phi, RN Steinmetz, M Shadman, SR Riddell, DG Maloney, CJ TurtleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.